IRIS
BRUNETTI, ORONZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.876
AS - Asia 1.623
EU - Europa 1.265
SA - Sud America 433
Continente sconosciuto - Info sul continente non disponibili 237
AF - Africa 75
OC - Oceania 3
AN - Antartide 1
Totale 8.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.741
SG - Singapore 651
IT - Italia 423
CN - Cina 335
BR - Brasile 328
SE - Svezia 225
HK - Hong Kong 202
RU - Federazione Russa 160
VN - Vietnam 136
FR - Francia 104
DE - Germania 94
GB - Regno Unito 85
IN - India 63
FI - Finlandia 50
CA - Canada 47
AR - Argentina 41
BD - Bangladesh 35
ID - Indonesia 31
TR - Turchia 28
BE - Belgio 25
CO - Colombia 21
MX - Messico 20
ZA - Sudafrica 20
PL - Polonia 17
CI - Costa d'Avorio 15
PK - Pakistan 15
IQ - Iraq 14
CR - Costa Rica 13
EC - Ecuador 13
VE - Venezuela 13
JP - Giappone 12
LT - Lituania 12
ES - Italia 11
UA - Ucraina 11
UZ - Uzbekistan 11
IL - Israele 10
MA - Marocco 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
SV - El Salvador 9
PR - Porto Rico 8
PH - Filippine 7
CL - Cile 6
ET - Etiopia 6
HN - Honduras 6
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
SA - Arabia Saudita 6
CH - Svizzera 5
GT - Guatemala 5
PY - Paraguay 5
AT - Austria 4
EG - Egitto 4
KR - Corea 4
KZ - Kazakistan 4
NI - Nicaragua 4
NL - Olanda 4
NP - Nepal 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
IE - Irlanda 3
KW - Kuwait 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
UY - Uruguay 2
AQ - Antartide 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KY - Cayman, isole 1
LU - Lussemburgo 1
Totale 8.263
Salva come PNG Salva come JPEG
Città #
Ashburn 531
Fairfield 519
Chandler 443
Singapore 373
Woodbridge 283
San Jose 254
Seattle 252
Cambridge 220
Houston 213
Milan 208
Hong Kong 198
Nyköping 182
Wilmington 172
Beijing 111
Ann Arbor 109
Dearborn 103
Council Bluffs 98
New York 80
Dallas 77
Lawrence 58
Los Angeles 58
Rome 56
Roxbury 55
Lauterbourg 51
Santa Clara 44
Ho Chi Minh City 42
Munich 41
Brooklyn 40
Des Moines 36
Boardman 34
São Paulo 32
The Dalles 30
Nanjing 29
Helsinki 26
Columbus 25
San Diego 25
Brussels 24
Dong Ket 24
Moscow 24
Hanoi 22
Jakarta 22
Bari 21
Turku 19
Chicago 18
Paris 17
Frankfurt am Main 16
Abidjan 15
Inglewood 15
Montreal 15
Chennai 14
Hefei 14
Phoenix 14
Turin 14
Buffalo 13
Figino 13
Orem 13
Pune 13
Warsaw 13
Da Nang 12
London 12
Tokyo 12
Atlanta 11
Denver 11
Marseille 11
San Francisco 11
Washington 11
Shanghai 10
Vilnius 10
Belo Horizonte 9
Johannesburg 9
Manchester 9
San Salvador 9
Stockholm 9
Tashkent 9
Guangzhou 8
Jinan 8
Lahore 8
Naples 8
Poplar 8
Rio de Janeiro 8
San Mateo 8
Düsseldorf 7
Miami 7
Mumbai 7
Nuremberg 7
San José 7
Amman 6
Augusta 6
Brno 6
Campinas 6
Curitiba 6
Dhaka 6
Edinburgh 6
Jacksonville 6
Kingston 6
Mexico City 6
Toronto 6
Addis Ababa 5
Baghdad 5
Blumenau 5
Totale 5.818
Salva come PNG Salva come JPEG
Nome #
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 264
Angiogenesis in adenosquamous cancer of pancreas 238
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 211
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 199
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 196
Fisiologia V Ed. 192
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 191
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 184
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 183
Targeting angiogenesis in biliary tract cancers: An open option 182
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 179
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 175
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 174
Bone metastases in biliary cancers: A multicenter retrospective survey 174
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 171
Systematic review of irreversible electroporation role in management of locally advanced pancreatic cancer 171
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 167
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 166
Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance 163
Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review 161
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 158
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 152
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 148
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 148
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 147
Management of patients with end-stage renal disease undergoing chemotherapy: Recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN) 145
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 144
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 144
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 144
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 143
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 142
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy 137
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 135
Immunotherapy for colorectal cancer: where are we heading? 133
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 130
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 129
The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy 128
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 124
Bone metastases in hepatocellular carcinoma: an emerging issue 124
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 121
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 120
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 116
Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets 113
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 113
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 113
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 113
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 106
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 103
Immune system and bone microenvironment: rationale for targeted cancer therapies 102
Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer. 102
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer 96
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 94
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies 89
null 81
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 77
null 67
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 67
Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma? 66
null 61
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 57
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 56
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 54
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis 30
Totale 8.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022420 0 0 0 0 20 45 17 30 37 46 68 157
2022/2023929 104 155 85 75 85 95 15 113 140 5 40 17
2023/2024324 19 59 15 28 33 95 7 9 3 7 3 46
2024/20251.210 53 11 85 51 47 111 103 107 44 79 197 322
2025/20262.612 405 115 168 281 326 124 258 80 272 215 63 305
2026/2027614 60 97 156 277 24 0 0 0 0 0 0 0
Totale 8.513